Astellas Pharma Inc. (4503) - Financials, balance sheet (quarterly)

1,447.5 JPY

4.5

0.31%

Last update Jul 18, 3:24 PM JST

Market closed

Day range

1,447.5

1,444

1,457

Previous close

1,452

Open

1,454.5

Access this stock data via API

Astellas Pharma Inc.

1,447.50

4.50

0.31%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Dec 2023
Total assets	3.3T	3.5T	3.6T	3.4T
Current assets	1.2T	1.2T	1.2T	1.1T
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	188.4B	293.0B	335.7B	254.0B
Other short term investments	29.9B	36.3B	28.8B	31.5B
Accounts receivable	632.5B	558.3B	535.0B	496.0B
Other receivables	—	—	—	—
Inventory	297.3B	260.2B	248.7B	226.0B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	363M	0	1.2B	1.2B
Hedging assets	—	—	—	—
Other current assets	39.2B	42.6B	32.2B	31.6B
Non current assets	2.1T	2.3T	2.4T	2.3T
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	2.0T	2.1T	2.3T	2.2T
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.1T	1.3T	1.5T	1.5T
Investments and advances	—	—	—	—
Other non current assets	28.6B	26.6B	18.6B	8.6B
Total liabilities	1.8T	1.9T	2.0T	1.9T
Current liabilities	1.1T	1.1T	1.3T	1.2T
Accounts payable	187.8B	161.2B	185.2B	150.4B
Accrued expenses	—	—	—	—
Short term debt	266.5B	307.3B	472.3B	407.2B
Deferred revenue	—	—	—	—
Tax payable	34.5B	36.0B	38.5B	34.8B
Pensions	—	—	—	—
Other current liabilities	535.3B	488.5B	476.5B	446.8B
Non current liabilities	764.7B	839.0B	687.9B	711.7B
Long term provisions	8.1B	4.5B	7.4B	5.4B
Long term debt	564.9B	620.2B	447.7B	463.8B
Provision for risks and charges	3.2B	9.8B	2.2B	2.2B
Deferred liabilities	5.4B	23.6B	51.3B	70.0B
Derivative product liabilities	—	—	—	—
Other non current liabilities	53.6B	46.7B	49.0B	44.1B
Shareholders equity
Common stock	103.0B	103.0B	103.0B	103.0B
Retained earnings	740.9B	817.6B	809.4B	838.6B
Other shareholders equity	—	—	—	—
Total shareholders equity	1.5T	1.5T	1.6T	1.5T
Additional paid in capital	185.3B	183.5B	184.1B	183.0B
Treasury stock	37.5B	38.0B	33.8B	34.1B
Minority interest	—	—	—	—